Liabilities / Assets
57th percentile
Higher debt load relative to assets than 57% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.10x
Liabilities / Revenue
59th percentile
Higher debt load relative to revenue than 59% of similar nonprofits.
Net Margin
24th percentile
Higher net margin than 24% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
35th percentile
Faster asset growth than 35% of similar nonprofits.
Revenue Growth
57th percentile
Faster revenue growth than 57% of similar nonprofits.
Balance Sheet
Assets
Down$4,435,160
Down $141,581 (-3.1%) from 2021
Net Assets
Down$3,975,079
Down $203,983 (-4.9%) from 2021
Liabilities
Up$460,081
Up $62,402 (+16%) from 2021
Revenue And Expenses
Revenue
Up$3,308,156
Up $332,834 (+11%) from 2021
Expenses
Down$3,523,580
Down $348,354 (-9.0%) from 2021
Net Income
Up-$215,424
Up $681,188 (+76%) from 2021
Historical Trend
Filing Detail Status
This 2022 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2022 to Dec 31, 2022
Mission and Program Overview
Mission
To provide a collaborative infrastructure to make progress in the prevention, diagnosis and treatment of sarcoma.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2022 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $4,435,160
- Liabilities
- $460,081
- Net assets
- $3,975,079
- Revenue
- $3,308,156
- Expenses
- $3,523,580
- Net income
- -$215,424